FIELD: medicine.
SUBSTANCE: presence or absence of diabetes is established, platelet aggregation, initial level of plasminogen-1 activator inhibitor and the degree of Willebrand factor activity in blood plasma is determined prior to surgery, the values are evaluated in points. According to the total value of the indices, the risk of adverse cardiac events for the patient under study is assessed. In case of the total score equal to or more than 2 - a high risk of adverse cardiac events after percutaneous coronary intervention is established.
EFFECT: method can reliably assess the risk of adverse events after percutaneous coronary intervention for patients with stable coronary heart disease.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ADVERSE OUTCOMES WITHIN THE FIRST YEAR FOLLOWING THE PERCUTANEOUS CORONARY INTERVENTION WITH STENTING IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | 2018 |
|
RU2692257C1 |
| METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ANTIAGGREGANT THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2011 |
|
RU2486523C1 |
| METHOD FOR THROMBOCYTE AGGREGATION ACTIVITY DETERMINATION FOR PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2619858C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN THE LATE PERIOD AFTER ACUTE CORONARY SYNDROME | 2017 |
|
RU2663935C1 |
| METHOD FOR ASSESSING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING A PERCUTANEOUS CORONARY INTERVENTION | 2019 |
|
RU2734993C1 |
| METHOD OF INDIVIDUAL PROGNOSIS OF CLINICAL EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2639772C1 |
| METHOD FOR PROTECTING MYOCARDIUM FROM ISCHEMIC DAMAGE IN PATIENTS WITH STABLE CHD WHEN CONDUCTING INTERCUTANEOUS CORONARY INTERVENTIONS | 2018 |
|
RU2680385C1 |
| METHOD OF PREDICTING UNFAVOURABLE ANNUAL OUTCOME IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ELEVATION OF ST SEGMENT AFTER PERCUTANEOUS CORONARY INTERVENTION | 2012 |
|
RU2502459C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF RESTENOSIS OF CORONARY ARTERY AFTER STENTING WITH BARE METAL OR DRUG-ELUTING STENT IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2748010C1 |
| METHOD FOR PREDICTION OF ANTIPLATELET THERAPY EFFICIENCY REDUCTION RISK | 2016 |
|
RU2623051C1 |
